ID   HAP1 PPP2R5D (-)
AC   CVCL_TG11
SY   HZGHC003155c003; PPP2R5D knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG11
DR   Horizon_Discovery; HZGHC003155c003
DR   Wikidata; Q54877194
RX   PubMed=39935523;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9312; PPP2R5D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
RX   PubMed=39935523; DOI=10.12688/f1000research.145146.2; PMCID=PMC11811605;
RA   Ayoubi R., Fotouhi M., Alende C., Southern K., Laflamme C.;
RG   ABIF Consortium;
RG   NeuroSGC/YCharOS/EDDU Collaborative Group;
RT   "A guide to selecting high-performing antibodies for
RT   serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit
RT   delta isoform (PPP2R5D) for use in western blot, immunoprecipitation
RT   and immunofluorescence.";
RL   F1000Research 13:1.1-1.18(2024).
//